Gut Microbial Metabolites in Alzheimer’s Disease: A Liver-Centered Perspective on the Gut–Liver–Brain Axis
Microorganisms · 11.11.2026 · 14 (11) · 2606
DOI: 10.3390/microorganisms14112606 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microorganisms, online erschienen am 11.11.2026. Verfasst von Pengfei Chen und 8 weiteren Autor:innen. Die Arbeit nennt 185 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shandong Provincial Natural Science Foundation, Shandong Provincial Medical and Health Science and Technology Project.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by β-amyloid deposition and tau hyperphosphorylation. Multiple communication pathways link the central nervous system (CNS), liver, and gut microbiota, collectively forming the gut–liver–brain axis, in which the liver serves as a metabolic and immune hub. Emerging evidence suggests that this axis may be involved in AD pathogenesis. Among gut microbiota-associated metabolites, short-chain fatty acids (SCFAs), bile acids (BAs), and trimethylamine N-oxide (TMAO) have been linked to AD pathology and may modulate metabolic and inflammatory pathways involved in pathogenesis. This review summarizes current evidence on their roles in AD progression within the gut–liver–brain axis, with particular emphasis on hepatic metabolism and hepatic immune regulation within this axis. It also discusses hepatic and neuronal autophagy as potential links between metabolic disturbances, mitochondrial dysfunction, and AD pathology. Finally, the potential of targeting different components of this axis is discussed as a direction for future therapeutic research.
Förderung
- National Natural Science Foundation of China
- Shandong Provincial Natural Science Foundation
- Shandong Provincial Medical and Health Science and Technology Project
Zitieren
APA
Chen, P., Liang, Q., Liu, X., Yang, D., Si, Y., Yang, J., Li, X., Zheng, W., & Li, N. (2026). Gut Microbial Metabolites in Alzheimer’s Disease: A Liver-Centered Perspective on the Gut–Liver–Brain Axis. Microorganisms, 14(11), 2606. https://doi.org/10.3390/microorganisms14112606
Vancouver
Chen P, Liang Q, Liu X, Yang D, Si Y, Yang J, et al. Gut Microbial Metabolites in Alzheimer’s Disease: A Liver-Centered Perspective on the Gut–Liver–Brain Axis. Microorganisms. 2026;14(11):2606. doi:10.3390/microorganisms14112606
BibTeX
@article{Chen2026,
author = {Chen, Pengfei and Liang, Qi and Liu, Xi and Yang, Di and Si, Yingfan and Yang, Juan and Li, Xin and Zheng, Wenxiang and Li, Ning},
title = {Gut Microbial Metabolites in Alzheimer’s Disease: A Liver-Centered Perspective on the Gut–Liver–Brain Axis},
journal = {Microorganisms},
year = {2026},
volume = {14},
number = {11},
pages = {2606},
doi = {10.3390/microorganisms14112606}
}
EUVIMED